A Multidisciplinary Approach to the Management of Breast Cancer, Part 2: Therapeutic Considerations
Keywords: تابش جزئی پستان; AI; aromatase inhibitor; DCIS; ductal carcinoma in situ; CYP2D6; cytochrome P450 2D6; DFS; disease-free survival; FDA; Food and Drug Administration; FEC; fluorouracil, epirubicin, and cyclophosphamide; LHRH; luteinizing hormone-releasing hormone; NSABP; N